Skip to main content

Intensive BP Reduction Effective for Lowering All-Cause Dementia Risk

Medically reviewed by Carmen Pope, BPharm. Last updated on April 29, 2025.

By Elana Gotkine HealthDay Reporter

TUESDAY, April 29, 2025 -- An intensive blood pressure (BP) reduction intervention is effective for lowering the risk for all-cause dementia among individuals aged 40 years and older with untreated hypertension, according to a study published online April 21 in Nature Medicine.

Jiang He, M.D., Ph.D., from UT Southwestern Medical Center in Dallas, and colleagues randomly assigned 163 villages in rural China to a nonphysician community health care provider-led intervention and 163 villages to usual care to examine the effectiveness of BP reduction on dementia among 33,995 individuals aged 40 years and older with untreated hypertension. Trained nonphysician community health care providers in the intervention group initiated and titrated antihypertensive medications according to a simple stepped-care protocol to achieve a systolic/diastolic BP goal of <130/<80 mm Hg, with primary care physician supervision.

The researchers found that the net reductions in systolic and diastolic BP were 22.0 and 9.3 mm Hg, respectively, over 48 months in the intervention group compared with usual care. The intervention group had a significantly lower primary outcome of all-cause dementia than the usual care group (risk ratio, 0.85). The intervention group also had less frequent serious adverse events (risk ratio, 0.94).

"The effectiveness of BP reduction on the risk of dementia was consistent across subgroups based on age, sex, education, history of cigarette smoking, body mass index, systolic BP, fasting plasma glucose and 10-year atherosclerotic cardiovascular disease risk at baseline," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted April 2025

Read this next

Lorundrostat Beneficial for BP Reduction in Uncontrolled Hypertension

WEDNESDAY, April 30, 2025 -- For patients with uncontrolled and treatment-resistant hypertension, lorundrostat is associated with greater reductions in blood pressure than...

32 Percent of Dementia Attributed to Audiometric Hearing Loss

MONDAY, April 28, 2025 -- The population attributable fraction of dementia from any audiometric hearing loss is 32.0 percent, according to a study published online April 17 in...

Moderately Preterm Birth Tied to Long-Term Cognitive Problems

FRIDAY, April 25, 2025 -- Moderately preterm birth is associated with cognitive problems at ages 9 to 10 years, according to a study published online April 14 in JAMA Network...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.